
Saphronix Pharmaceuticals Private Limited
Founded in February 2025 and headquartered in Telangana, India.
Founded in February 2025 and headquartered in Telangana, India.
Saphronix Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 February 2025 ( 14 days old ). Its registered office is in Medak, Telangana, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shashi Pathak and Aparna Pandey serve as directors at the Company.
Medak, Telangana, India
+91-XXXXXXXXXX
U21000TS2025PTC194649
194649
Private Limited Indian Non-Government Company
26 Feb 2025
-
-
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shashi Pathak ![]() | Director | 26-Feb-2025 | Current |
Aparna Pandey | Director | 26-Feb-2025 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Saphronix Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Shashi Pathak is a mutual person
Shashi Pathak is a mutual person
Shashi Pathak is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Saphronix Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Saphronix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saphronix Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shashi Pathak was appointed as a Director was appointed as a Director on 26 Feb 2025 & has been associated with this company since 14 days .
Aparna Pandey was appointed as a Director was appointed as a Director on 26 Feb 2025 & has been associated with this company since 14 days .
Saphronix Pharmaceuticals Private Limited was registered on 26 Feb 2025 with Roc Hyderabad & aged 14 days as per MCA records.
Saphronix Pharmaceuticals Private Limited was incorporated on 26 Feb 2025.
The authorized share capital of Saphronix Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Saphronix Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Saphronix Pharmaceuticals Private Limited is S N4 D No.6-35/28A Ground Floor, Mallareddy Enclave India, Ramachandrapuram, Telangana, 502032.
The corporate identification number (CIN) of Saphronix Pharmaceuticals Private Limited is U21000TS2025PTC194649 and the company number is 194649 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.